Samuel Taylon, MD
Neurological Surgery · Merriam, KSNPI 1891923850
Payments from drug & device makers
What this record shows
Globus Medical accounts for 65.9% of it on its own, with 9 other manufacturers making up the rest. Reporting peaked in 2024 at $994 and has fallen 68.1% since, to $317 in 2025.
Across 33 payments — averaging $87.24 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Globus Medical$2K
- Medtronic$382
- Nalu Medical, Inc.$140
- Abbott$126
- SPR Therapeutics, Inc$90
- Saluda Medical Americas, Inc.$86
- plus $156 from 4 others
What the payments were for
- Travel & lodging$1,32746%
- Food & beverage$1,55254%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Globus Medical | 19 | $1,899 |
| Medtronic(2 entities) | 4 | $382 |
| Nalu Medical, Inc. | 1 | $140 |
| Abbott | 1 | $126 |
| SPR Therapeutics, Inc | 2 | $90 |
| Saluda Medical Americas, Inc. | 1 | $86 |
| Carlsmed, Inc. | 1 | $58 |
| Orthofix Medical, Inc. | 2 | $38 |
| Integra Lifesciences Corporation | 1 | $34 |
| Si-bone, Inc. | 1 | $26 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Excelsius Robotics System$677
- MazorX - Renaissance$141
- Nalu Neurostimulation System$140
- ASSURE$139
- Proclaim IPG$126
How this compares
$2,879 in reported general payments places this provider in the 65th percentile of 63 neurological surgery providers in Kansas.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 13 | $270 |
| Methocarbamol | 17 | $233 |
| Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen | 18 | $198 |
| Methylprednisolone | 12 | $87 |
Paid to pharmacies, not to this prescriber.
Other neurological surgery in Merriam
- Matthew PiersonMerriam$1K
- Raymond GrundmeyerWichita$1.9M
- Matthew HenryWichita$1.9M
- John DickersonWichita$1.9M
- Frank HolladayKansas City$349K
- Koji EbersoleKansas City$123K
- Anthony AlvaradoKansas City$80K
- Jeremy PetersonKansas City$28K
- Justin DavisKansas City$24K
- Sarah WoodrowKansas City$21K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.